Panel Supports the Approval of Vigabatrin for Seizures, Spasms

ROCKVILLE, MD. — A federal advisory panel has unanimously supported the approval of vigabatrin, an antiepileptic drug that is currently available in more than 50 other countries, as an adjunctive treatment of refractory complex partial seizures in adults and as a treatment for infantile spasms.